Zobrazeno 1 - 10
of 82
pro vyhledávání: '"David C.L. Lam"'
Autor:
Xue Li, Kuan Peng, Franco W.T. Cheng, David C.L. Lam, Ching Lung Cheung, Celine S.L. Chui, Francisco T.T. Lai, Eric Y.F. Wan, Carlos K.H. Wong, Tiantian Ma, Samson H.H. Yum, Esther W.Y. Chan, Jian Dong Huang, Chak Sing Lau, Mary S.M. Ip, Ian C.K. Wong
Publikováno v:
Journal of Infection. 86:256-308
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a127d7d5dd02a7b94c255aba84035eb1
https://doi.org/10.1016/j.jinf.2022.12.016
https://doi.org/10.1016/j.jinf.2022.12.016
Autor:
John D. Minna, David C.L. Lam
Related Articles from How Do We Safely Get People to Stop Smoking?
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::632056fcdf2d333883f94fb7e051b8cd
https://doi.org/10.1158/1940-6207.22525001.v1
https://doi.org/10.1158/1940-6207.22525001.v1
Autor:
John D. Minna, David C.L. Lam
Nicotine replacement therapy (NRT) is a valuable, proven, and U.S. Food and Drug Administration–approved tool for smoking cessation. However, the discoveries of functional nicotinic acetylcholine receptors (nAChR) on lung epithelial and cancer cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e11313c66989b8ec3637b6ed19d0b27a
https://doi.org/10.1158/1940-6207.c.6544526
https://doi.org/10.1158/1940-6207.c.6544526
Autor:
James Chung-Man Ho, Terence Chi-Chun Tam, Mary S.M. Ip, Pak-Leung Ho, Chun-Him Hui, KP Chan, David C.L. Lam, Ting-Fung Ma, Wang‐Chun Kwok, Julie Kwan-Ling Wang
Publikováno v:
Annals of the American Thoracic Society
Rationale: Patients with asthma were advised to avoid coronavirus disease (COVID-19) and comply with medication during the COVID-19 pandemic. Respiratory tract infection is a common cause of asthma exacerbations. There has not been evidence suggestin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f515dbd869944a3dba099600e5b887fc
https://doi.org/10.1513/annalsats.202010-1247oc
https://doi.org/10.1513/annalsats.202010-1247oc
Autor:
Ka Yan Chiang, Terence Chi Chun Tam, Wang Chun Kwok, James Chung-Man Ho, David C.L. Lam, Mary S.M. Ip
Publikováno v:
Clinical Cancer Drugs. 8:137-145
Background: As the commonest EGFR-TKI being used in Hong Kong, gefitinib has shown to be efficacious and safe as first-line treatment for L858R mutation and exon 19 deletions with less gastrointestinal and cutaneous adverse events than erlotinib and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::295c56381b8763b3222f0a82287308a0
https://doi.org/10.2174/2212697x08666211029142257
https://doi.org/10.2174/2212697x08666211029142257
Autor:
Terence Chi Chun Tam, James Chung-Man Ho, Ka Yan Chiang, Mary S.M. Ip, David C.L. Lam, Wang Chun Kwok
Publikováno v:
Journal of Chemotherapy. 32:429-436
Maintenance chemotherapy was studied in first line setting for advanced stage non-small cell lung carcinoma (NSCLC). There has not been any data on the role of continuation maintenance chemotherapy in second line setting. A retrospective cohort study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b1cc307459995230c48ec36e54656f5
https://doi.org/10.1080/1120009x.2020.1829325
https://doi.org/10.1080/1120009x.2020.1829325
Autor:
Terence Chi Chun Tam, James Chung-Man Ho, David C.L. Lam, Mary S.M. Ip, Wang Chun Kwok, Macy Mei Sze Lui
Publikováno v:
Clinical Cancer Drugs. 7:57-61
Background: Gefitinib was approved by the Food and Drug Administration (FDA) of the United States (US) for the treatment of advanced non-small cell carcinoma harboring sensitizing epidermal growth factor receptor (EGFR) mutations. The use of gastric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::407e88764432b9f0cd4e16d523e763d1
https://doi.org/10.2174/2212697x06666191021155535
https://doi.org/10.2174/2212697x06666191021155535
Autor:
Macy Mei Sze Lui, David C.L. Lam, Ka Yan Chiang, Mary S.M. Ip, Peony W C Chong, Terence Chi Chun Tam, James Chung-Man Ho, Yun Chor Gary Lee
Publikováno v:
Respirology. 25:1167-1173
BACKGROUND AND OBJECTIVE The advent of effective anti-cancer therapy has brought about uncertainty on the benefit of early definitive measures for newly diagnosed MPE from lung cancer. This study aims to investigate the outcomes of MPE in this settin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d02b9e690f58904b5f18de41edd4fb9e
https://doi.org/10.1111/resp.13812
https://doi.org/10.1111/resp.13812
Publikováno v:
Cancers
Volume 13
Issue 21
Cancers, Vol 13, Iss 5345, p 5345 (2021)
Volume 13
Issue 21
Cancers, Vol 13, Iss 5345, p 5345 (2021)
Simple Summary Lung cancer is strongly associated with tobacco smoking. Nicotine in tobacco smoke can be transformed into a carcinogen after in vivo metabolism. However, the mechanism of how nicotine metabolites modulate a pro-tumorigenic microenviro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b11254b5eb1913fa1232fa17185d912
Autor:
James Chung-Man Ho, David C.L. Lam, Terence Chi Chun Tam, Wang Chun Kwok, Ka Yan Chiang, Mary S.M. Ip
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 162
Background Nephrotoxicity is one of the concerns of prolonged maintenance therapy with pemetrexed. No reversible risk factors for pemetrexed-induced nephrotoxicity have been identified in previous studies. Identification of such factors would be clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec6fd513a30480d39920d995d86c3db0
https://pubmed.ncbi.nlm.nih.gov/34823107
https://pubmed.ncbi.nlm.nih.gov/34823107